Redian新闻
>
post-doc position available at Columbia University
avatar
post-doc position available at Columbia University# Biology - 生物学
E*E
1
Title: Postdoctoral fellow in the Mace Lab at Columbia University Irving
Medical Center
Position Summary: The goal of this project is to define the requirement for
the eukaryotic DNA helicase in human natural killer (NK) cell development.
This project arises from the study of human NK cell deficiency, and we have
extensive experience in the use of primary human cells to model and
manipulate human NK cell development in vitro. Positions are currently open
on an NIH-funded project with the aim of understanding why mutations in the
eukaryotic DNA helicase lead to isolated human NK cell deficiency and
extreme susceptibility to viral infection and malignancy.
What we offer:
● A supportive environment with the opportunity for intellectual and
professional growth
● Opportunities to gain experience in cutting edge genetic and cell
biological techniques, including in vitro modeling of human immune cell
differentiation
● Excellent environment and resources at Columbia University in New York
NY
● Fully funded position (renewed annually for up to 5 years)
What we seek:
● Collaborative, ambitious individuals with a strong interest in our
research and environment
● Ability to work independently to develop research projects and mentor
others
● Fearlessness in the design and implementation of new techniques and
approaches to model human immune cell function
● Strong verbal and written communication skills
● Experience with human immune cells an asset
Application Materials
● CV
● Cover letter including a paragraph describing how your research
interests fit with the job described
● Contact information for 3 references
● Email to: [email protected]
CUIMC is an equal opportunity employer and we are proud to promote and
cultivate diversity in science.
avatar
a*a
2
人在国内可以么?
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。